Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -Q1 group results

Aug 8 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             9.27                8.49             52.50    
                 (+9.1 pct)          (-7.4 pct)       (+16.6 pct) 
  Operating       loss 1.80           loss 1.63           2.50    
                                                      (+10.5 pct) 
  Recurring       loss 1.84           loss 1.50           2.50    
                                                      (-3.6 pct)  
  Net             loss 1.51           loss 1.05           1.30    
                                                      (+24.8 pct) 
  EPS          loss 12.55 yen       loss 8.70 yen      10.08 yen  
  Ann Div                             17.00 yen        17.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             17.00 yen        17.00 yen  
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news